Must Asset Management’s Zymeworks ZYME Stock Holding History

Must Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,405	Closed	-$214K	–	39
2020 Q4	$214K	Buy	+4,405	New	+$205K	0.15%	30

Other funds holding ZYME

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Must Asset Management's ZYME Position: Q1 2021 in Review

Must Asset Management sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 4,405 shares — an estimated $214K sold.

Must Asset Management first reported a position in ZYME in Q4 2020 and held it in 1 quarter. The position peaked at $214K in Q4 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

Must Asset Management reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
Must Asset Management sold 4,405 Zymeworks shares in Q1 2021, an estimated $214K.
Must Asset Management first reported a position in Zymeworks in Q4 2020 and held it in 1 quarter.
Must Asset Management's Zymeworks position peaked at $214K in Q4 2020.
125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on Must Asset Management's 13F filing for Q1 2021, filed 11 May 2021.